From November 28, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on November 30, 2023.
Chemclin Diagnostics Co., Ltd.
Equities
688468
CNE100005311
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.54 CNY | +0.46% |
|
-2.53% | -39.39% |
21/05 | Shareholders to Cut Up to 2% Stake in Chemclin Diagnostics | MT |
03/05 | Chemclin Diagnostics Launches Homegrown Immunodetection Kits | MT |
1st Jan change | Capi. | |
---|---|---|
-39.39% | 356M | |
-10.79% | 11.41B | |
-11.02% | 7.53B | |
+30.85% | 5.62B | |
-16.28% | 3.82B | |
+8.39% | 2.6B | |
-64.67% | 2.37B | |
-10.17% | 2.26B | |
+24.87% | 2.16B | |
-12.06% | 1.71B |
- Stock Market
- Equities
- 688468 Stock
- News Chemclin Diagnostics Co., Ltd.
- Tranche Update on Chemclin Diagnostics Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.